NCT07626996

Brief Summary

The study aims to compare laparoscopic-assisted radical hysterectomy with open radical hysterectomy in women with early-stage cervical cancer. A total of 60 patients diagnosed with FIGO stage IA1, IA2, and IB1 cervical cancer were enrolled and randomly assigned into two equal groups: laparoscopic surgery and open surgery. All patients underwent total hysterectomy, bilateral adnexectomy, and pelvic lymph node dissection. Perioperative outcomes were evaluated, including operative time, blood loss, complications, and hospital stay, as well as long-term oncological outcomes such as recurrence, recurrence-free survival, and overall survival. Patients were followed for up to three years postoperatively. The findings of this study aim to assess the safety, feasibility, and clinical effectiveness of laparoscopic-assisted surgery compared with the conventional open approach in the management of early-stage cervical cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
Last Updated

June 4, 2026

Status Verified

March 1, 2026

Enrollment Period

2.9 years

First QC Date

March 27, 2026

Last Update Submit

May 30, 2026

Conditions

Keywords

Radical HysterectomyLaparoscopic SurgeryEarly-Stage Cervical CancerMinimally Invasive Surgery

Outcome Measures

Primary Outcomes (3)

  • Operative Time

    The surgery duration will be measured in minutes from skin incision to closure.

    Intraoperative period (day of surgery)

  • Intraoperative Blood Loss volume

    Assessment of volume of intraoperative blood loss (mL): Estimated blood loss volume measured in millilitres during surgery.

    Intraoperative period

  • Length of Hospital Stay

    Duration of hospital stay measured in days from surgery to discharge

    Up to 30 days post-surgery

Secondary Outcomes (1)

  • Recurrence Rate

    Up to 3 years postoperatively

Study Arms (2)

Laparoscopic Radical Hysterectomy

EXPERIMENTAL

In this study, participants underwent radical hysterectomy with bilateral adnexectomy and lymph node dissection using a laparoscopic approach, and vaginal stump closure using an endoscopic stapler was performed.

Procedure: Laparoscopic Radical Hysterectomy

Open Radical Hysterectomy

ACTIVE COMPARATOR

Under conventional surgical techniques in this group , participants underwent open abdominal radical hysterectomy with bilateral adnexectomy and dissection of pelvic lymph nodes.

Procedure: Open Radical Hysterectomy

Interventions

In this procedure, a minimally invasive laparoscopic-assisted radical hysterectomy is performed, including dissection of the pelvic lymph nodes and closure of the vaginal stump with an endoscopic stapler.

Laparoscopic Radical Hysterectomy

A standard open abdominal radical hysterectomy includes dissection of the pelvic lymph nodes and the closure of the vaginal stump.

Open Radical Hysterectomy

Eligibility Criteria

Age38 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • FIGO stage IA1, IA2, IB1
  • patients with a tumor size \< 2 cm by MRI or pathological assessment after conization
  • tumours with histopathological subtypes: squamous cell carcinoma, adenocarcinoma and adeno-squamous carcinoma (
  • patients with adequate; hematopoietic, renal and liver functions:
  • patients with BMI \< 35 (
  • patients with age range 38 - 65 years old.

You may not qualify if:

  • patients with mental, heart, bladder, liver, or kidney illness
  • patients who had received pre-operative chemotherapy or radiotherapy pregnant patients
  • patients with incomplete data or lost follow-up
  • patients with radiological evidence of invasion of the outer 1/3 of the cervical stroma or the lower uterine segment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig University Hospitals

Zagazig, Sharqia Province, Egypt

Location

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Ola A Harb, Professor

    Zagazig University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is an open-label study due to the nature of the surgical interventions, where neither participants nor investigators were blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study Participants were assigned into two parallel groups to undergo either laparoscopic-assisted radical hysterectomy or open radical hysterectomy. The study compares perioperative and long-term oncological outcomes between the two surgical approaches.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2026

First Posted

June 4, 2026

Study Start

March 1, 2021

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

June 4, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Data contains patient information

Locations